Bicisate is a diagnostic radiopharmaceutical agent primarily utilized in nuclear medicine as a complex with technetium-99m for single-photon emission computed tomography (SPECT) imaging of cerebral perfusion… Read more
Bicisate is a diagnostic radiopharmaceutical agent primarily utilized in nuclear medicine as a complex with technetium-99m for single-photon emission computed tomography (SPECT) imaging of cerebral perfusion to assist in the localization of strokes. The compound, also known as ethyl cysteinate dimer, requires high-precision analytical support during its development and production. This category provides a comprehensive range of reference standards, including identified impurities such as N-nitroso bicisate, which are essential for rigorous impurity profiling and compliance with regulatory quality control standards. Additionally, the list includes stable isotope-labelled compounds that serve as critical internal standards for accurate mass spectrometry-based bioanalytical method validation and the study of metabolic pathways. These high-purity reference materials enable pharmaceutical laboratories to ensure consistent formulation quality and diagnostic accuracy when characterizing the pharmacokinetic profile and chemical integrity of this diagnostic tracer.